173 related articles for article (PubMed ID: 11543682)
1. [99mTc]oxotechnetium(V) complexes amine-amide-dithiol chelates with dialkylaminoalkyl substituents as potential diagnostic probes for malignant melanoma.
Friebe M; Mahmood A; Bolzati C; Drews A; Johannsen B; Eisenhut M; Kraemer D; Davison A; Jones AG
J Med Chem; 2001 Sep; 44(19):3132-40. PubMed ID: 11543682
[TBL] [Abstract][Full Text] [Related]
2. '3+1' mixed-ligand oxotechnetium(V) complexes with affinity for melanoma: synthesis and evaluation in vitro and in vivo.
Friebe M; Mahmood A; Spies H; Berger R; Johannsen B; Mohammed A; Eisenhut M; Bolzati C; Davison A; Jones AG
J Med Chem; 2000 Jul; 43(14):2745-52. PubMed ID: 10893312
[TBL] [Abstract][Full Text] [Related]
3. 99mTc(I)/Re(I) tricarbonyl complexes for in vivo targeting of melanotic melanoma: Synthesis and biological evaluation.
Moura C; Gano L; Mendes F; Raposinho PD; Abrantes AM; Botelho MF; Santos I; Paulo A
Eur J Med Chem; 2012 Apr; 50():350-60. PubMed ID: 22397924
[TBL] [Abstract][Full Text] [Related]
4. [99mTcOAADT]-(CH2)2-NEt2: a potential small-molecule single-photon emission computed tomography probe for imaging metastatic melanoma.
Cheng Z; Mahmood A; Li H; Davison A; Jones AG
Cancer Res; 2005 Jun; 65(12):4979-86. PubMed ID: 15958536
[TBL] [Abstract][Full Text] [Related]
5. Development of novel mixed-ligand oxotechnetium [SNS/S] complexes as potential 5-HT1A receptor imaging agents.
Papagiannopoulou D; Pirmettis I; Maina T; Pelecanou M; Nikolopoulou A; Chiotellis E; Raptopoulou CP; Vlahos AT; Terzis A; Papadopoulos M; Chiotellis E
J Biol Inorg Chem; 2001 Mar; 6(3):256-65. PubMed ID: 11315561
[TBL] [Abstract][Full Text] [Related]
6. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
7. Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives.
Tzanopoulou S; Pirmettis IC; Patsis G; Raptopoulou C; Terzis A; Papadopoulos M; Pelecanou M
Inorg Chem; 2006 Jan; 45(2):902-9. PubMed ID: 16411729
[TBL] [Abstract][Full Text] [Related]
8. Melanoma uptake of (99m)Tc complexes containing the N-(2-diethylaminoethyl)benzamide structural element.
Eisenhut M; Mohammed A; Mier W; Schönsiegel F; Friebe M; Mahmood A; Jones AG; Haberkorn U
J Med Chem; 2002 Dec; 45(26):5802-5. PubMed ID: 12477363
[TBL] [Abstract][Full Text] [Related]
9. Tridentate ligands containing the SNS donor atom set as a novel backbone for the development of technetium brain-imaging agents.
Mastrostamatis SG; Papadopoulos MS; Pirmettis IC; Paschali E; Varvarigou AD; Stassinopoulou CI; Raptopoulou CP; Terzis A; Chiotellis E
J Med Chem; 1994 Sep; 37(20):3212-8. PubMed ID: 7932548
[TBL] [Abstract][Full Text] [Related]
10. Novel oxorhenium and oxotechnetium complexes from an aminothiol[NS]/thiol[S] mixed-ligand system.
Bouziotis P; Pirmettis I; Pelecanou M; Raptopoulou CP; Terzis A; Papadopoulos M; Chiotellis E
Chemistry; 2001 Sep; 7(17):3671-80. PubMed ID: 11575768
[TBL] [Abstract][Full Text] [Related]
11. Novel 99mTc aminobisthiolato/monothiolato "3 + 1" mixed ligand complexes: structure-activity relationships and preliminary in vivo validation as brain blood flow imaging agents.
Pirmettis IC; Papadopoulos MS; Chiotellis E
J Med Chem; 1997 Aug; 40(16):2539-46. PubMed ID: 9258360
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of a novel 99mTc cyclopentadienyl tricarbonyl complex ([(Cp-R)99mTc(CO)3]) for sigma-2 receptor tumor imaging.
Chen X; Cui MC; Deuther-Conrad W; Tu YF; Ma T; Xie Y; Jia B; Li Y; Xie F; Wang X; Steinbach J; Brust P; Liu BL; Jia HM
Bioorg Med Chem Lett; 2012 Oct; 22(20):6352-7. PubMed ID: 22995625
[TBL] [Abstract][Full Text] [Related]
13. Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent.
Choi SR; Yang B; Plössl K; Chumpradit S; Wey SP; Acton PD; Wheeler K; Mach RH; Kung HF
Nucl Med Biol; 2001 Aug; 28(6):657-66. PubMed ID: 11518647
[TBL] [Abstract][Full Text] [Related]
14. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy.
Polyakov V; Sharma V; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
Bioconjug Chem; 2000; 11(6):762-71. PubMed ID: 11087323
[TBL] [Abstract][Full Text] [Related]
15. Technetium glucose complexes as potential cancer imaging agents.
Dapueto R; Aguiar RB; Moreno M; Machado CM; Marques FL; Gambini JP; Chammas R; Cabral P; Porcal W
Bioorg Med Chem Lett; 2015 Oct; 25(19):4254-9. PubMed ID: 26318991
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 99mTc-nitrido heterocomplex of piperidine and in vitro and in vivo evaluation of its affinity for sigma receptors.
Satpati D; Bapat K; Sarma HD; Kothari K; Venkatesh M; Banerjee S
Cancer Biother Radiopharm; 2008 Feb; 23(1):34-42. PubMed ID: 18298327
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of novel oxotechnetium (99Tc and 99mTc) and oxorhenium complexes from the 2,2'-bipyridine (NN)/thiol (S) mixed-ligand system.
Papachristou M; Pirmettis IC; Tsoukalas C; Papagiannopoulou D; Raptopoulou C; Terzis A; Stassinopoulou CI; Chiotellis E; Pelecanou M; Papadopoulos M
Inorg Chem; 2003 Sep; 42(18):5778-84. PubMed ID: 12950229
[TBL] [Abstract][Full Text] [Related]
18. Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization.
Eisenhut M; Hull WE; Mohammed A; Mier W; Lay D; Just W; Gorgas K; Lehmann WD; Haberkorn U
J Med Chem; 2000 Oct; 43(21):3913-22. PubMed ID: 11052796
[TBL] [Abstract][Full Text] [Related]
19. Novel cyclopentadienyl tricarbonyl (99m)tc complexes containing 1-piperonylpiperazine moiety: potential imaging probes for sigma-1 receptors.
Wang X; Li D; Deuther-Conrad W; Lu J; Xie Y; Jia B; Cui M; Steinbach J; Brust P; Liu B; Jia H
J Med Chem; 2014 Aug; 57(16):7113-25. PubMed ID: 25073047
[TBL] [Abstract][Full Text] [Related]
20. Novel oxorhenium and oxotechnetium MO(NS)(S)2 complexes in the development of 5-HT1A receptor imaging agents.
Tsoukalas C; Pirmettis I; Patsis G; Pelecanou M; Bodo K; Raptopoulou CP; Terzis A; Papadopoulos M; Chiotellis E
J Inorg Biochem; 2003 Jan; 93(3-4):213-20. PubMed ID: 12576284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
